CA2131621A1 - Selective alteration of antibody immunogenicity - Google Patents

Selective alteration of antibody immunogenicity

Info

Publication number
CA2131621A1
CA2131621A1 CA 2131621 CA2131621A CA2131621A1 CA 2131621 A1 CA2131621 A1 CA 2131621A1 CA 2131621 CA2131621 CA 2131621 CA 2131621 A CA2131621 A CA 2131621A CA 2131621 A1 CA2131621 A1 CA 2131621A1
Authority
CA
Canada
Prior art keywords
antibody
antibodies
response
reduced
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2131621
Other languages
English (en)
French (fr)
Inventor
Thomas R. Sykes
Mark A. Reddish
Richard P. Baum
Antoine A. Noujaim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncothyreon Canada Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2131621A1 publication Critical patent/CA2131621A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1078—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an immunoglobulin, i.e. being an (anti)-anti-idiotypic antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA 2131621 1992-03-18 1993-03-18 Selective alteration of antibody immunogenicity Abandoned CA2131621A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85360592A 1992-03-18 1992-03-18
US07/853,605 1992-03-18

Publications (1)

Publication Number Publication Date
CA2131621A1 true CA2131621A1 (en) 1993-09-30

Family

ID=25316485

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2131621 Abandoned CA2131621A1 (en) 1992-03-18 1993-03-18 Selective alteration of antibody immunogenicity

Country Status (7)

Country Link
EP (1) EP0631507A1 (fi)
JP (1) JPH07504668A (fi)
AU (1) AU3881593A (fi)
CA (1) CA2131621A1 (fi)
FI (1) FI944314A0 (fi)
NO (1) NO943388L (fi)
WO (1) WO1993018792A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121041A0 (en) * 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
JP2002504154A (ja) * 1997-06-17 2002-02-05 アルタレックス コーポレイション 治療用組成物および治療方法
BR112012017051A2 (pt) 2009-12-23 2017-12-05 Esbatech Alcon Biomed Res Unit método para diminuir a imunogenicidade

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816249A (en) * 1981-11-17 1989-03-28 The Board Of Trustees Of The Leland Stanford Junior University Monoclonal anti-idiotype antibodies
US4661586A (en) * 1981-11-17 1987-04-28 The Board Of Trustees Of The Leland Stanford Junior University Monoclonal anti-idiotype antibodies

Also Published As

Publication number Publication date
WO1993018792A1 (en) 1993-09-30
NO943388D0 (no) 1994-09-12
NO943388L (no) 1994-11-18
AU3881593A (en) 1993-10-21
FI944314A (fi) 1994-09-16
EP0631507A1 (en) 1995-01-04
JPH07504668A (ja) 1995-05-25
FI944314A0 (fi) 1994-09-16

Similar Documents

Publication Publication Date Title
ES2141467T5 (es) Anticuerpos anti-cd30 que evitan la escision proteolitica y liberacion del antigeno cd30 fijado a la membrana.
Schultes et al. Anti-idiotype induction therapy: Anti-CA125 antibodies (Ab 3) mediated tumor killing in patients treated with Ovarex mAb B43. 13 (Ab 1)
US20080131443A1 (en) Method and composition for reconforming multi-epitopic antigens to intiate an immune response
KR920700692A (ko) 사람의 종양과 연합한 신규 항원에 대한 신규의 일클론 항체
AU1572992A (en) Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen
US20010047083A1 (en) Murine anti-idiotype antibody 3H1
HU194497B (en) Process for producing compositions for provocating immunreply against tumors and virus
US5084396A (en) Enhanced production of antibodies utilizing insolubilized immune complexes
Losman et al. Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti‐idiotype antibody
CA2131621A1 (en) Selective alteration of antibody immunogenicity
AU732505B2 (en) Therapeutic composition and method of treatment
NZ231037A (en) Anti-idiotypic monoclonal antibody of an antibody which binds to an epitope of a tumour-associated gp 72 protein, cell line and composition
US20070092522A1 (en) Method and composition for reconforming multi-epitopic antigens to initiate an immune response
JP3122124B2 (ja) 新規抗イディオタイプモノクローナル抗体
FI111518B (fi) Menetelmä monoklonaalisten vasta-aineiden ja vasta-ainetta sisältävän farmaseuttisen koostumuksen valmistamiseksi
AU711270C (en) Method and composition for reconforming multi-epitopic antigens to initiate an immune response
MXPA04008685A (es) Anticuerpos ab1?? especificos contra el antigeno ca 125 asociado a tumores.
Viale et al. Characterization of Idiotypic Reagents as Antigen Surrogates of a Human Tumor-Associated Antigen
JPH01228493A (ja) 坑イディオタイプ坑体
NZ503032A (en) Use of a binding agent to reconforming multi-epitopic antigens to initiate an immune response
WO1998008090A1 (en) Anti-idiotypic antibodies to an epiglycanin
MXPA98004982A (en) Monoclonal antibody, murine, anti-idiotipo, 11d10, and methods for use

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead